title: Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers.
authors: Division of Hypertension and Clinical Pharmacology, CHUV, Lausanne, Switzerland.
authors: M
authors: M
authors: Burnier
authors: T
authors: T
authors: Buclin
authors: J
authors: J
authors: Biollaz
authors: J
authors: J
authors: Nussberger
authors: B
authors: B
authors: Waeber
authors: H R
authors: HR
authors: Brunner
mesh_terms: D000804:Angiotensin II / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000493:pharmacokinetics / Q000494:pharmacology; D001562:Benzimidazoles / Q000493:pharmacokinetics / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics / Q000494:pharmacology; D000077405:Irbesartan; D019808:Losartan; D011355:Prodrugs / Q000493:pharmacokinetics / Q000494:pharmacology; D012016:Reference Values; D013777:Tetrazoles / Q000493:pharmacokinetics / Q000494:pharmacology
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D007093:Imidazoles; D011355:Prodrugs; D013777:Tetrazoles; D000804:Angiotensin II; D000077405:Irbesartan; D019808:Losartan; C077793:candesartan cilexetil